Adre du Plessis

Adre du Plessis

Auto-generated profile, based on publicly available information

Adre du Plessis

The George Washington University School of Medicine, District of Columbia, United States

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2016 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
MBM. Brossard-Racine
M. Brossard-Racine
APA. du Plessis
A. du Plessis
GVG. Vezina
G. Vezina
RRR. Robertson
R. Robertson
MDMary Donofrio
Mary Donofrio
CLCatherine Limperopoulos
Catherine Limperopoulos
BACKGROUND AND PURPOSE: Brain injury in neonates with congenital heart disease is an important predictor of adverse neurodevelopmental outcome. Impaired brain development in congenital heart disease may have a prenatal origin, but the sensitivity and specificity of fetal brain MR imaging for predicting neonatal brain lesions are currently unknown. We sought to determine the value of conventional fetal MR imaging for predicting abnormal findings on neonatal preoperative MR imaging in neonates with complex congenital heart disease. MATERIALS AND METHODS: MR imaging studies were performed in 103 fetuses with confirmed congenital heart disease (mean gestational age, 31.57 ± 3.86 weeks) and were repeated postnatally before cardiac surgery (mean age, 6.8 ± 12.2 days). Each MR imaging study was read by a pediatric neuroradiologist. RESULTS: Brain abnormalities were detected in 17/103 (16%) fetuses by fetal MR imaging and in 33/103 (32%) neonates by neonatal MR imaging. Only 9/33 studies with abnormal neonatal findings were preceded by abnormal findings on fetal MR imaging. The sensitivity and specificity of conventional fetal brain MR imaging for predicting neonatal brain abnormalities were 27% and 89%, respectively. CONCLUSIONS: Brain abnormalities detected by in utero MR imaging in fetuses with congenital heart disease are associated with higher risk of postnatal preoperative brain injury. However, a substantial proportion of anomalies on postnatal MR imaging were not present on fetal MR imaging; this result is likely due to the limitations of conventional fetal MR imaging and the emergence of new lesions that occurred after the fetal studies. Postnatal brain MR imaging studies are needed to confirm the presence of injury before open heart surgery.

1 October 2020 in NeuroImage
Verified
Journal Article
Open access
JAJosepheen De Asis-Cruz
Josepheen De Asis-Cruz
KKKushal Kapse
Kushal Kapse
SBSudeepta K. Basu
Sudeepta K. Basu
MSMariam Said
Mariam Said
DSDustin Scheinost
Dustin Scheinost
CLCatherine Limperopoulos
Catherine Limperopoulos
Brain structural changes in preterm infants appear before term age. Functional differences between premature infants and healthy fetuses during this period have yet to be explored. Here, we examined brain connectivity using resting state functional MRI in 25 very premature infants (VPT; gestational age at birth <32 weeks) and 25 healthy fetuses with structurally normal brain MRIs. Resting state data were evaluated using seed-based correlation analysis and network-based statistics using 23 regions of interest (ROIs) per hemisphere. Functional connectivity strength, the Pearson correlation between blood oxygenation level dependent signals over time across all ROIs, was compared between groups. In both cohorts, connectivity between homotopic ROIs showed a decreasing medial to lateral gradient. The cingulate cortex, medial temporal lobe and the basal ganglia shared the strongest connections. In premature infants, connections involving superior temporal, hippocampal, and occipital areas, among others, were stronger compared to fetuses. Premature infants showed stronger connectivity in sensory input and stress-related areas suggesting that extra-uterine environment exposure alters the development of select neural networks in the absence of structural brain injury.

24 September 2015 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
IEI.E. Evangelou
I.E. Evangelou
APA.J. du Plessis
A.J. du Plessis
GVG. Vezina
G. Vezina
RNR. Noeske
R. Noeske
CLCatherine Limperopoulos
Catherine Limperopoulos
BACKGROUND AND PURPOSE: 1H-MRS provides a noninvasive way to study fetal brain maturation at the biochemical level. The purpose of this study was to characterize in vivo metabolic maturation in the healthy fetal brain during the second and third trimester using 1H-MRS. MATERIALS AND METHODS: Healthy pregnant volunteers between 18 and 40 weeks gestational age underwent single voxel 1H-MRS. MR spectra were retrospectively corrected for motion-induced artifacts and quantified using LCModel. Linear regression was used to examine the relationship between absolute metabolite concentrations and ratios of total NAA, Cr, and Cho to total Cho and total Cr and gestational age. RESULTS: Two hundred four spectra were acquired from 129 pregnant women at mean gestational age of 30.63 ± 6 weeks. Total Cho remained relatively stable across the gestational age (r2 = 0.04, P = .01). Both total Cr (r2 = 0.60, P < .0001) as well as total NAA and total NAA to total Cho (r2 = 0.58, P < .0001) increased significantly between 18 and 40 weeks, whereas total NAA to total Cr exhibited a slower increase (r2 = 0.12, P < .0001). Total Cr to total Cho also increased (r2 = 0.53, P < .0001), whereas total Cho to total Cr decreased (r2 = 0.52, P < .0001) with gestational age. The cohort was also stratified into those that underwent MRS in the second and third trimesters and analyzed separately. CONCLUSIONS: We characterized metabolic changes in the normal fetal brain during the second and third trimesters of pregnancy and derived normative metabolic indices. These reference values can be used to study metabolic maturation of the fetal brain in vivo.

30 March 2021 in Radiology
Verified
Journal Article
Closed access
ZZZungho Zun
Zungho Zun
KKKushal Kapse
Kushal Kapse
MJMarni Jacobs
Marni Jacobs
SBSudeepta Basu
Sudeepta Basu
MSMariam Said
Mariam Said
CLCatherine Limperopoulos
Catherine Limperopoulos
Regional cerebral blood flow in preterm infants increased with advancing postmenstrual age during the third trimester and was lower in infants with intraventricular hemorrhage and medically managed... Background The third trimester of gestation is a crucial phase of rapid brain development, but little has been reported on the trajectories of cerebral blood flow (CBF) in preterm infants in this p...

15 February 2024 in Clinical Neurophysiology
Verified
Journal Article
Closed access
VCVenkata C. Chirumamilla
Venkata C. Chirumamilla
LHLaura Hitchings
Laura Hitchings
SMSarah B. Mulkey
Sarah B. Mulkey
TATayyba Anwar
Tayyba Anwar
RBRobin Baker
Robin Baker
RGRathinaswamy B Govindan
Rathinaswamy B Govindan

11 November 2021 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
SBS.K. Basu
S.K. Basu
SPS. Pradhan
S. Pradhan
SBS.D. Barnett
S.D. Barnett
MMM. Mikkelsen
M. Mikkelsen
KKK.J. Kapse
K.J. Kapse
CLCatherine Limperopoulos
Catherine Limperopoulos
Objective To investigate the relationship between history of metformin use and delirium risk, as well as long-term mortality. Methods In this retrospective cohort study, subjects recruited between January 2016 and March 2020 were analyzed. Logistic regression analysis was performed to investigate the relationship between metformin use and delirium. Log-rank analysis and Cox proportional hazards model were used to investigate the relationship between metformin use and 3-year mortality. Results The data from 1404 subjects were analyzed. 242 subjects were categorized into a DM-without-metformin group, and 264 subjects were categorized into a DM-with-metformin group. Prevalence of delirium was 36.0% in the DM-without-metformin group, and 29.2% in the DM-with-metformin group. A history of metformin use reduced the risk of delirium in patients with DM (OR, 0.50 [95% CI, 0.32 to 0.79]) after controlling for age, sex, and dementia status, body mass index (BMI), and insulin use. The 3-year mortality in the DM-without-metformin group (survival rate, 0.595 [95% CI, 0.512 to 0.669]) was higher than in the DM-with-metformin group (survival rate, 0.695 [95% CI, 0.604 to 0.770]) (p=0.035). A history of metformin use decreased the risk of 3-year mortality after adjustment for age, sex, Charlson Comorbidity Index, BMI, history of insulin use, and delirium status (HR, 0.69 [95% CI, 0.48 to 0.98]). Conclusions It was found that metformin usage was associated with decreased delirium prevalence and lower 3-year mortality. The potential benefit of metformin on delirium risk and mortality were shown.